8-K
Current Report
REVIVA PHARMACEUTICALS HOLDINGS, INC. Filed Acc 0001437749-22-018020
Agreement ended
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading rvph20220726_8k.htm…